5 Biotech Stocks to Buy According to Billionaire Ken Fisher

In this article, we discuss the 5 biotech stocks to buy according to billionaire Ken Fisher. If you want to read our detailed analysis of these stocks, go directly to the 10 Biotech Stocks to Buy According to Billionaire Ken Fisher.

5. Edwards Lifesciences Corporation (NYSE:EW)

Number of Hedge Fund Holders: 43

Edwards Lifesciences Corporation (NYSE:EW) provides healthcare equipment for critical care. Regulatory filings show that Fisher Asset Management owned 6.2 million shares in Edwards Lifesciences Corporation (NYSE:EW) at the end of the third quarter of 2021 worth over $727 million. 

Edwards Lifesciences Corporation (NYSE:EW) recently posted earnings for the third quarter, beating market predictions on earnings per share by $0.02. The revenue over the period was $1.3 billion, up 14% year-on-year. 

At the end of the third quarter of 2021, 43 hedge funds in the database of Insider Monkey held stakes worth $2.1 billion in Edwards Lifesciences Corporation (NYSE:EW), down from 47 in the preceding quarter worth $2 billion. 

In its Q3 2021 investor letter, Wedgewood Partners highlighted a few stocks and Edwards Lifesciences Corporation (NYSE:EW) was one of them. Here is what the fund said:

“Edwards Lifesciences returned to a double-digit 2-year growth rate during the quarter. Lifesaving medical procedures, such as severe aortic stenosis valve replacement, got back to some semblance of normal in the late stages of the pandemic. The Company is still in the early years of leading the charge of replacing open surgical procedures with minimally invasive transcatheter therapies. As medical visits continue to return to normal, Edwards should be able to expand its lead, particularly after a major competitor has had issues with product efficacy. Edwards should be able to maintain its market leadership by focusing its higher than peer average research and development budget on just a handful of product lines.”